This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Biofrontera Zukünftiges Wachstum
Future Kriterienprüfungen 5/6
Wichtige Informationen
44.5%
Wachstumsrate der Gewinne
42.1%
EPS-Wachstumsrate
| Pharmaceuticals Gewinnwachstum | 19.4% |
| Wachstumsrate der Einnahmen | 22.0% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2024 | 40 | 3 | 1 | 2 | 1 |
| 12/31/2023 | 31 | 0 | -4 | -3 | 1 |
| 12/31/2022 | 26 | -38 | -9 | -9 | 1 |
| 6/30/2022 | 31 | 10 | 33 | 33 | N/A |
| 3/31/2022 | 30 | 15 | N/A | N/A | N/A |
| 12/31/2021 | 29 | 38 | 30 | 30 | N/A |
| 9/30/2021 | 28 | -16 | N/A | N/A | N/A |
| 6/30/2021 | 27 | -16 | -8 | -7 | N/A |
| 3/31/2021 | 29 | -12 | N/A | N/A | N/A |
| 12/31/2020 | 30 | -13 | -4 | -3 | N/A |
| 9/30/2020 | 33 | -17 | N/A | N/A | N/A |
| 6/30/2020 | 33 | -22 | -14 | -12 | N/A |
| 3/31/2020 | 31 | -10 | N/A | N/A | N/A |
| 12/31/2019 | 31 | -7 | -35 | -33 | N/A |
| 9/30/2019 | 26 | 1 | N/A | N/A | N/A |
| 6/30/2019 | 26 | 8 | -29 | -28 | N/A |
| 3/31/2019 | 23 | -8 | N/A | N/A | N/A |
| 12/31/2018 | 21 | -9 | -14 | -13 | N/A |
| 9/30/2018 | 19 | -14 | -13 | -13 | N/A |
| 6/30/2018 | 16 | -15 | -12 | -12 | N/A |
| 3/31/2018 | 14 | -16 | N/A | N/A | N/A |
| 12/31/2017 | 12 | -16 | -14 | -13 | N/A |
| 9/30/2017 | 11 | -18 | -16 | -16 | N/A |
| 6/30/2017 | 9 | -16 | -16 | -16 | N/A |
| 3/31/2017 | 8 | -14 | -15 | -15 | N/A |
| 12/31/2016 | 6 | -11 | -11 | -10 | N/A |
| 9/30/2016 | 4 | -9 | -9 | -8 | N/A |
| 6/30/2016 | 4 | -7 | -6 | -6 | N/A |
| 3/31/2016 | 4 | -9 | N/A | -8 | N/A |
| 12/31/2015 | 4 | -11 | N/A | -10 | N/A |
| 9/30/2015 | 4 | -12 | N/A | -10 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: B8FE's forecast earnings growth (44.5% per year) is above the savings rate (-0.01%).
Ertrag vs. Markt: B8FE's earnings (44.5% per year) are forecast to grow faster than the German market (9.8% per year).
Hohe Wachstumserträge: B8FE's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: B8FE's revenue (22% per year) is forecast to grow faster than the German market (3.8% per year).
Hohe Wachstumseinnahmen: B8FE's revenue (22% per year) is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if B8FE's Return on Equity is forecast to be high in 3 years time